The studies reported here were designed to ascertain whether or not the new iJ-lactam antibiotic, temocillin, would produce antibio.tic-associated 
Antibiotic-associated colitis is one of the most severe reactions to antimicrobial drug administration known, and can be fatal if left untreated. The most important causative organism is Clostridium difjicile, although Clostridium perjringens has been incriminated in some cases (Borriello et aI., 1984) . The reported frequency of antibiotic-associated colitis varies widely, but has been estimated at less than 0.1 % of treated patients, although 5% or more of hospitalised patients may develop antibioticassociated colitis during nosocomial outbreaks (Fekety, 1983) . In humans, the disease is characterised by massive watery diarrhoea, and endoscopic examination shows ulceration of the colonic mucosa and exudative plaques which coalesce to form a pseudomembrane. C. difficile produces 2 major toxins, a cytotoxin and an enterotoxin. The characterisation of these toxins is now fairly detailed (Burdon et aI., 1981; Sullivan et aI., 1982; Taylor et aI., 1981) but, although the cytotoxin has I Presented only during the poster session. been shown to cause major colonic damage, the inter-relationship of these toxins in the aetiology of antibiotic-associated colitis is still unclear.
C. difficile is not a normal component of the faecal flora in adults (Borriello, 1981) and recent studies by Sebald (1983) suggest that this organism is harboured in relatively low numbers by 3 to 5% of healthy subjects. C. difficile can also be isolated from soil, water, hospital floors and infected abdominal wounds (Fekety, 1983) . Antibiotic administration is considered to produce an imbalance in the gut flora, allowing the acquisition and proliferation of this toxigenic organism (Wilson et aI., 1981) .
All the major classes of antibacterial agents are now recognised as potential inducers of antibioticassociated colitis regardless of their activity against C. difficile (Bartlett and Taylor, 1982) . Considerable advances have been made in the understanding of antibiotic-associated colitis using animal models of colitis. The hamster model is the most widely used, and has been extensively reviewed by Silva (1979) . The majority of antibiotics which produce antibiotic-associated colitis in humans also produce the disease in hamsters. Therefore, the hamster model is regarded as a sensitive indicator of antibiotics likely to cause antibiotic-associated colitis in treated patients.
Temocillin is a novel semisynthetic fj-lactam antibiotic with a methoxy group substituted in the 6-a position in the nucleus (Bentley and Clayton, 1977) . This compound shows exceptional stability to a wide range of bacterial fj-lactamases and has an unusual spectrum of activity. Temocillin has been found to be active against most members of the Enterobacteriaceae, Haemophilus influenzae and Neisseria gonorrhoeae; however it was not found to be active against Gram-positive bacteria, Pseudomonas aeruginosa and anaerobes, including C. difficile (Slocombe et aI., 1981) .
The aim of these studies was to ascertain whether or not temocillin would produce antibiotic-associated colitis in the hamster model. Clindamycin and cefoxitin were used as control antibiotics, since they have been well documented as being capable of causing antibiotic-associated 58 colitis in this model (Bartlett and Taylor, 1982; Ebright et aI., 1981) .
Materials and Methods

l.l Animals
Male golden Syrian hamsters, weighing 70 to 80g, were housed individually in a separate conventional animal room with an adjacent access room. The hamsters were fed on the Labsure CRMX and given diet and water ad libitum.
Antibiotics and Antibiotic Administration
Temocillin disodium (Beecham Research laboratories, Batch No. PI83), cefoxitin sodium (Merck, Sharp and Dohme), clindamycin phosphate (Up john) and vancomycin hydrochloride (Eli Lilly and Co.) were used.
The dose regimens employed were as follows. Firstly, groups of 5 hamsters were given a single dose of the antibiotics either subcutaneously or orally. Clindamycin was given at I mg/hamster, and the remaining antibiotics at 1, 10 and 100 mg/ hamster subcutaneously and 10 mg/hamster orally in O.5ml of phosphate buffered saline. Secondly, hamsters were given I and IOmg doses of temocillin or cefoxitin subcutaneously 3 times daily for 4 days to determine the effect of multiple dosing, and lastly, to ascertain whether the animals could be protected from clindamycin-induced colitis, hamsters receiving Img ofclindamycin orally were dosed concomitantly with 10mg of either temocillin or vancomycin orally. Treatment with temocillin and vancomycin was continued once daily for a further 3 days, and control animals received phosphate buffered saline. Selection of the doses was guided by those most commonly used in previously reported studies (Ebright et aI., 1981) .
Monitoring the Production of Antibiotic-Associated Colitis
The hamsters were weighed at the time of dosing and their daily weight changes were recorded for 10 or 20 days after dosing. Each animal was examined for signs of diarrhoea and its cage and bedding was inspected for the state of the stools. TDso values (time taken for 50% of the population to die) were calculated and at death, or at the termination of the experiments, the entire length of the intestine was examined for signs of haemorrhage and distension characteristic of antibioticassociated colitis in this model (Silva, 1979) .
The caecal contents were collected and their appearance was noted, prior to dilution with an equal volume of sterile saline. The samples were centrifuged at 3000 rpm for 15 minutes, and the supernatants rendered free of bacteria by passage through a 0.451Lm membrane filter (Millipore). Tissue culture toxin assays were performed on the supernatants, using mouse fibroblast cells according to the method of Borriello (1978) .
Antibiotic Concentrations in Blood and Caecal Contents
The concentrations of temocillin, cefoxitin and c1indamycin in the blood and caecal filtrates were measured following a single oral or subcutaneous 59 dose of 10 mgfhamster; with groups of 5 animals being sacrificed at intervals up to 6 hours after dosing. Samples of blood were collected by cardiac puncture into heparinised tubes (heparin 5000 units/ml), and supernatants of the caecal contents were prepared as previously described, with antibiotic concentrations being determined using a large-plate agar diffusion assay. Blood samples were assayed against standards prepared in horse blood, and phosphate buffer standards were used for the caecal contents. The assay organisms employed were Pseudomonas aeruginosa NCTC 10701 for temocillin, Bacillus subtilis A TCC 6633 for cefoxitin, and Staphylococcus aureus NCTC 6571 for c1indamycin.
Results
Assessment of Antibiotic-Associated Colitis
Subcutaneous Administration
The data in table I illustrate the effects of single subcutaneous doses of c1indamycin, cefoxitin, temocillin and saline. The median day of death (TDso) for hamsters given lmg c1indamycin was 5 days; prior to this all the animals gained weight normally but had diarrhoea to a greater or lesser extent. At post mortem, marked haemorrhage and distension of the caecum, ileum, and colon were noted, and caecal filtrates from all the c1indamycin-treated hamsters were cytotoxic down to at least a 10-4 dilution. This cytotoxicity was neutralised by Clostridium sordellii antitoxin, indicative of high C. difficile cytotoxin levels. Of the hamsters given lmg cefoxitin subcutaneously, 60% were alive at the termination of the experiment (TDso > 10 days) and showed no evidence of antibiotic-associated colitis at post mortem. However, the animals who died during the study had diarrhoea prior to death, and high toxin levels were present in their caecal filtrates, despite the fact that no gross pathological abnormalities were observed. The incidence of antibiotic-associated colitis was greater at the higher dose levels of cefoxitin, with the TDso values being reduced to 3 and 6 days for the 10 and 100mg doses, respectively. Prior to death, the animals showed a weight loss of approximately 109, and 80 to 100% had diarrhoea. On examination at post mortem, 60 to 80% had haemorrhagic caecitis and 100% had high C. difficile toxin levels in the caecal filtrates.
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In contrast, none of the animals which had received temocillin or saline died; instead they showed a normal weight gain throughout. None of the pathological features indicative of antibioticassociated colitis were present at post mortem and the caecal filtrates from these animals were all toxinnegative. Additionally, the response in animals given either temocillin or cefoxitin at I and lOmg subcutaneously 3 times daily for 4 days was no different than that observed following a single dose (results not reported).
A histopathological study of the caeca, from the animals given a single subcutaneous dose, showed a variety of findings. The response to c1indamycin I mg varied between animals; from a few polymorphs and slight congestion in the lamina propria to a moderate haemorrhagic congestion of the entire mucosa with necrosis and sloughing of the superficial glandular epithelium. An increase in dose to 10mg c1indamycin accentuated these effects, such that marked haemorrhagic congestion and necrosis of the entire mucosa was observed in some samples and areas of erosion to the full depth of the mucosa in others. An acute inflammatory reaction was evident in all samples. Cefoxitin produced a similar response; there being marked necrosis and sloughing of the entire superficial and Table II c Toxin titres for these 3 animals individually were 101, 1()3 and 10 4 • glandular epithelium, except for occasional basal glandular elements. The remaining lamina propria showed moderate congestion and cellular infiltration. Temocillin-treated animals at all dose levels and the saline control animals showed only a few polymorphs in the lamina propria (both regarded as being within normal limits).
Oral Administration
When the antibiotics were given as a single oral dose, clindamycin Img and cefoxitin 10mg induced antibiotic-associated colitis in a manner similar to the subcutaneous dose (table II) . The TDso values were 5 and 3 days for clindamycin and cefoxitin, respectively, and the majority of the hamsters had diarrhoea, haemorrhagic caecitis and high caecal C. difjicile cytotoxin levels. Again, none of the temocillin-or saline-treated hamsters developed antibiotic-associated colitis.
The data in table III illustrate the effects of dosing hamsters with either vancomycin or temocillin concomitantly with clindamycin. Hamsters receiving a single 10mg oral dose of vancomycin alone developed antibiotic-associated colitis, albeit much more slowly than cefoxitin-or clindamycininduced antibiotic-associated colitis. 80% of the animals had diarrhoea, and 60% had high caecal cytotoxin levels. The protective effects of vancomycin therapy are illustrated by the delayed onset of clindamycin-induced antibiotic-associated colitis, such that the TDso for this group was 13 days compared with 5 days for clindamycin alone, following which the animals succumbed to antibioticassociated colitis. Treatment with temocillin neither expedited nor delayed the onset of clindamycin-induced antibiotic-associated colitis.
Results of Antibiotic Concentrations in Blood and Caecal Contents
The results in table IV illustrate the antibiotic concentrations achieved following a 10mg oral or subcutaneous dose. Following oral administration, both temocillin and cefoxitin were undetectable in the blood, but produced a high sustained concentration in the caecum (> 600 mgjL for 6 hours). In contrast, parenteral administration oftemocillin and cefoxitin produced caecum concentrations considerably lower than those seen after oral administration. Blood concentrations of temocil- lin, however, were high (peak concentration III mgjL blood) and still detectable at 6 hours. Cefoxitin, however, was only present for I hour in the blood, with a peak value 00.5 mg/L. Clindamycin was poorly absorbed by both routes of administration, producing low prolonged blood concentrations, in contrast to the high concentrations detected in the caecal contents over the 6-hour period. Interestingly, the difference between the caecal concentrations following oral or subcutaneous administration of clindamycin was not as marked as that seen with temocillin and cefoxitin.
Discussion
The hamster has been well documented as being a sensitive indicator for the assessment of antibacterial agents likely to cause antibiotic-associated colitis in humans. In keeping with data reported in the literature, clindamycin and cefoxitin were shown to produce severe colitis in the hamster following oral and parenteral administration. How-ever, according to a number of parameters used to monitor the development of antibiotic-associated colitis, temocillin was shown not to produce the disease. The animals showed normal weight gain during the studies, and no gross pathological abnormalities were observed on autopsy. Results from histopathology have shown that caeca from hamsters dosed with temocillin were normal, whereas a moderate to very marked haemorrhagic caecitis was evident in the caeca of hamsters which received cefoxitin. These observations were confirmed by the absence of neutralisable C. difJicile cytotoxin in the caecal contents of temocillintreated hamsters.
Measurement of the antibiotic blood and caecal concentrations showed temocillin to be poorly absorbed by the oral route, giving rise to high concentrations in the caeca. In contrast, temocillin was well absorbed following parenteral administration, producing high concentrations in the blood and concentrations in the caeca that were considerably lower than those seen following oral administration. Nevertheless, regardless of the temocillin concentrations in the caeca, hamsters remained unsusceptible to colitis. Following dosage with clindamycin and cefoxitin, the majority of the animals showed evidence of colitis despite the fact that the caecal concentrations of these antibiotics ranged from low to high depending on the route of administration.
Studies in mice and in humans by de Vries Hospers et al. (1982) have shown that temocillin caused a reduction in the faecal counts of aerobic enteric bacilli but had no effect on the anaerobic bacterial population. There was no decrease in colonisation resistance following temocillin therapy, presumably because the anaerobic flora remained undisturbed. In a similar manner, the absence of antibiotic-associated colitis in the hamster following temocillin treatment was probably due to the lack of activity of temocillin against the anaerobic flora, thereby maintaining resistance to colonisation by exogenous C. difJicile. It is hoped that these data will suggest a favourable outlook for temocillin therapy in humans in that the compound is unlikely to cause changes in the gastrointestinal flora which would predispose to the development of antibiotic-associated colitis.
